Shanghai Celliver Biotechnology Co., Ltd. was established in Zhangjiang High-tech Park in 2013, rooted in the field of cell and regenerative medicine, focusing on developing life-saving cell therapies, and is committed to becoming a worldwide pioneer company leading cell-based treatment for many medically refractory liver diseases including NASH, cirrhosis and end-stage liver diseases.